RecruitingNCT03836521
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
The International Multicenter Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
Sponsor
Cedars-Sinai Medical Center
Enrollment
2,000 participants
Start Date
Aug 15, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Eligibility
Min Age: 19 YearsMax Age: 129 Years
Inclusion Criteria4
- Age≥18 years.
- Severe aortic stenosis with bicuspid anatomy.
- NYHA≥2 and/or syncope and/or angina.
- Patient judged by the Heart Team as indicated for TAVR.
Exclusion Criteria3
- Age <18 years
- Asymptomatic patients
- Pure aortic regurgitation.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICETranscatheter aortic valve replacement
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03836521
Related Trials
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT057392531 location
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
NCT068171481 location
Bicuspid Aortic Valve (BAV) Registry
NCT017562221 location
Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic Valve
NCT061534071 location